Have details of our agreement with QUT ever been disclosed? From what I've read Professor Upton, lead inventor of VitroGro and our Chief Scientific Officer, was a co-founder of Tissue Therapies when it was spun off from QUT in 2003/4. Could be seen a conflict of interest? If we are still paying quarterly research fees to QUT I'd like to know if it is in the interest of progressing our CE Mark application. If not, it would reasonable to suspend these until such time as commercialisation is achieved.
TIS Price at posting:
10.5¢ Sentiment: Hold Disclosure: Held